Dr. Seth Forman to Chair XBiotech’s Second Phase 2 Study of Bermekimab in Atopic Dermatitis

Ads

You May Also Like

Biocartis Group NV: Disclosure of a transparency notification

PRESS RELEASE: REGULATED INFORMATION 27 February 2018, 07:00 CET Disclosure of a transparency notification (Article ...

Selecta Biosciences Announces New Employment Inducement Grants

WATERTOWN, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a ...